班克西亚-西西因可以通过调节炎症反应和补充和凝血级联通路来改善结肠炎相关的结肠直肠癌
Qiang Chen1, Maoxu Wang1, Wei Shi1
1Institute of College of Pharmacy, Changchun University of Chinese Medicine, Changchun, 130117, People's Republic of China.
班克西亚-西克辛 (Banxia-Xiexin) (BXD) 显示出对结肠炎相关结肠直肠癌 (CAC) 的治疗潜力. 这种传统中医药通过调节关键代谢途径和炎症级联来减少炎症和瘤生长.
科学领域:
- 胃肠病学 胃肠病学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 大肠炎相关的结直肠癌 (CAC) 缺乏特定的治疗方法.
- 传统中医 (TCM) 像Banxia-Xiexin开 (BXD) 是用于炎症状况,但其在CAC中的作用是未知的.
研究的目的:
- 在CAC小鼠模型中评估BXD的治疗疗效.
- 阐明BXD对CAC的影响背后的分子机制.
主要方法:
- 使用氧甲/德克斯硫酸 (AOM/DSS) 诱导了一个CAC小鼠模型.
- 通过BXD或硫沙拉 (阳性对照) 和通过疾病指数,组织病理学和细胞因子水平评估治疗疗效.
- 利用代谢和蛋白质组分析来识别分子标和途径,通过qRT-PCR进行验证.
主要成果:
- BXD治疗显著减少了CAC临床症状,结肠炎症,瘤数量和大小.
- BXD显著降低了炎症性细胞因子 (TNF-α,IL-6,IL-1β,IFN-γ).
- 代谢学表明氨基酸和甘氨酸脂代谢的调节;蛋白质学显示补充和凝固级联中的丰富,其中关键蛋白质表达被BXD.逆转.
结论:
- BXD通过减少炎症和调节糖脂代谢来证明CAC的治疗潜力.
- 补体和凝血级联涉及到BXD的抗CAC作用.
- BXD需要进一步研究,以便在治疗CAC.中获得临床应用.
更多相关视频
08:34Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation
Published on: July 27, 2022
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
